Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020471

Chief Scientific Officer sold 1,384 shares at $0.34 ($471)

  • Chief Scientific Officer acquired 9,092 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-05 Exercise or conversion : show line 1 in the form 10b5-1 +4,546 54,596 D
2023-07-06 Exercise or conversion : show line 2 in the form 10b5-1 +4,546 59,142 D
2023-07-06 Sale : show line 3 in the form 10b5-1 −1,384 $0.34 $471 57,758 D
Open-market sales · 1,384 sh · avg $0.34 · $471

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2023-07-05 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Unit −4,546 4,546 145,454 D
2023-07-06 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit −4,546 4,546 140,908 D
Loading xslF345X04/form4.xml…